MSD New Zealand
A research-intensive biopharmaceutical subsidiary operating in New Zealand that conducts clinical research and supplies medicines and vaccines across oncology, vaccines and infectious diseases. Activities include discovery and development of medicines and vaccines, small-molecule process research and scale-up, partnerships and licensing, pharmacovigilance and distribution, sustainability programmes, and health awareness/patient education resources. The organisation participates in public-private collaborations and funds investigator-initiated clinical programmes.
Industries
N/A
Products
Prescription medicines and vaccines portfolio (New Zealand)
A local portfolio of prescription medicines and vaccines across therapeutic areas including oncology, infectious diseases, antivirals and antibiotics, supplied for New Zealand patients.
Prescription medicines and vaccines portfolio (New Zealand)
A local portfolio of prescription medicines and vaccines across therapeutic areas including oncology, infectious diseases, antivirals and antibiotics, supplied for New Zealand patients.
Services
Business development and licensing
Evaluation and collaboration on licensing and partnership opportunities across discovery to clinical-stage programmes.
Pharmacovigilance and safety reporting
Receiving and processing of adverse event reports and product complaints via dedicated phone and email channels.
Research collaborations and investigator support
Collaborative research programmes with governments, NGOs and academic partners, including funding support for investigator-initiated studies.
Patient education and health awareness materials
Development and provision of patient-facing educational content, including downloadable booklets and web-based information on disease stages, symptoms, risk factors and treatment pathways.
Business development and licensing
Evaluation and collaboration on licensing and partnership opportunities across discovery to clinical-stage programmes.
Pharmacovigilance and safety reporting
Receiving and processing of adverse event reports and product complaints via dedicated phone and email channels.
Research collaborations and investigator support
Collaborative research programmes with governments, NGOs and academic partners, including funding support for investigator-initiated studies.
Patient education and health awareness materials
Development and provision of patient-facing educational content, including downloadable booklets and web-based information on disease stages, symptoms, risk factors and treatment pathways.
Expertise Areas
- Clinical trial management
- Vaccine development
- Oncology drug development
- Infectious disease research
Key Technologies
- Small-molecule process chemistry
- Vaccine platform development
- Clinical trial design and management systems
- Adverse event reporting systems